EGF receptor promotes prostate cancer bone metastasis by downregulating miR-1 and activating TWIST1

Cancer Research

Volumn 75, Issue 15, 2015, Pages 3077-3086

  Chang, Yung Sheng ^a   Chen, Wei Yu ^b,c   Yin, Juan Juan ^d   Sheppard Tillman, Heather ^d   Huang, Jiaoti ^e   Liu, Yen Nien ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; MICRORNA 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MICRORNA; MIRN1 MICRORNA, HUMAN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR TWIST; TWIST1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; CELL NUCLEUS; COHORT ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; RNA STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ANIMAL; BONE TUMOR; DOWN REGULATION; DRUG SCREENING; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PROSTATE TUMOR; SECONDARY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE, NUDE; MICRORNAS; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA STABILITY; TWIST TRANSCRIPTION FACTOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84942873245     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-3380     Document Type: Article

References (37)

1. Di Lorenzo G., Tortora G, D'Armiento FP, De Rosa G, Staibano S, Autorino R, et al. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. Clin Cancer Res 2002; 8: 3438-44.
2. Traish AM, Morgentaler A. Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth. Br J Cancer 2009; 101: 1949-56.
3. Brand TM, Iida M, Li C., Wheeler DL. The nuclear epidermal growth factor receptor signaling network and its role in cancer. Discov Med 2011; 12: 419-32.
4. Maugeri-Sacca M., Coppola V, De Maria R, Bonci D. Functional role of microRNAs in prostate cancer and therapeutic opportunities. Crit Rev Oncog 2013; 18: 303-15.
5. Qin Q, Xu Y, He T., Qin C, Xu J. Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res 2012; 22: 90-106.
6. Kwok WK, Ling MT, Lee T.W., Lau TC, Zhou C, Zhang X, et al Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 2005; 65: 5153-62.
7. Lo HW, Hsu SC, Xia W, Cao X., Shih JY, Wei Y, et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 2007; 67: 9066-76.
8. Pala A, Karpel-Massler G, Kast R.E., Wirtz CR, Halatsch ME. Epidermal to mesenchymal transition and failure of EGFR-targeted therapy in glioblastoma. Cancers (Basel) 2012; 4: 523-30.
9. Nicoloso MS, Spizzo R, Shimizu M., Rossi S, Calin GA. MicroRNAs-the micro steering wheel of tumour metastases. Nat Rev Cancer 2009; 9: 293-302.
10. Lujambio A, Lowe SW The microcosmos of cancer. Nature 2012; 482: 347-55.
11. Ambs S, Prueitt RL, Yi M, Hudson R.S., Howe TM, Petrocca F, et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008; 68: 6162-70.
12. Hudson RS, Yi M, Esposito D., Watkins SK, Hurwitz AA, Yfantis HG, et al MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res 2012; 40: 3689-703.
13. Martens-Uzunova E.S., Jalava SE, Dits N.F., van Leenders GJ, Moller S, Trapman J, et al Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer. Oncogene 2012; 31: 978-91.
14. Liu YN, Yin JJ, Abou-Kheir W, Hynes P.G., Casey OM, Fang L, et al. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene 2013; 32: 296-306.
15. Yin JJ, Zhang L, Munasinghe J., Linnoila RI, Kelly K. Cediranib/AZD2171 inhibits bone and brain metastasis in a preclinical model of advanced prostate cancer. Cancer Res 2010; 70: 8662-73.
16. Yin J, Pollock C, Tracy K., Chock M, Martin P, Oberst M., et al. Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone. Mol Cell Biol 2007; 27: 7538-50.
17. Siu MK, Abou-Kheir W, Yin J.J., Chang YS, Barrett B, Suau F, et al Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance. Oncotarget 2014; 5: 3770-84.
18. Siu MK, Tsai YC, Chang Y.S., Yin JJ, Suau F, Chen WY, et al Transforming growth factor-beta promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway. Oncogene 2014 Dec 22. doi:10.1038/onc.2014.414.
19. Yin J, Liu YN, Tillman H, Barrett B., Hewitt S, Ylaya K, et al AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasis. Cancer Res 2014; 74: 4306-17.
20. Liu YN, Yin J, Barrett B., Sheppard-Tillman H, Li D, Casey O.M., et al. Loss of androgen-regulated MicroRNA 1 activates SRC and promotes prostate cancer bone metastasis. Mol Cell Biol 2015; 35: 1940-51.
21. Day CP, Carter J, Bonomi C., Esposito D, Crise B, Ortiz-Conde B, et al. Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study. Pigment Cell Melanoma Res 2009; 22: 283-95.
22. Taylor BS, Schultz N, Hieronymus H., Gopalan A, Xiao Y, Carver B.S., et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010; 18:11-22.
23. Lin SY, Makino K, Xia W., Matin A, Wen Y, Kwong K.Y., et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001; 3: 802-8.
24. Hanada N, Lo HW, Day C.P., Pan Y., Nakajima Y, Hung MC. Co-regulation of B-Myb expression by E2F1 and EGF receptor. Mol Carcinog 2006; 45: 10-7.
25. Lo HW, Cao X, Zhu H., Ali-Osman F. Cyclooxygenase-2 is a novel tran-scriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes. Mol Cancer Res 2010; 8: 232-45.
26. Jaganathan S, Yue P, Paladino D.C., Bogdanovic J., Huo Q, Turkson J. A functional nuclear epidermal growth factor receptor, SRC and Stat3 heteromeric complex in pancreatic cancer cells. PLoS ONE 2011; 6: e19605.
27. Schlomm T, Kirstein P, Iwers L., Daniel B, Steuber T, Walz J., et al. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer. Clin Cancer Res 2007; 13: 6579-84.
28. Lo HW, Ali-Seyed M, Wu Y., Bartholomeusz G, Hsu SC, Hung MC Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1. J Cell Biochem 2006; 98: 1570-83.
29. Cao H, Lei ZM, Bian L, Rao CV Functional nuclear epidermal growth factor receptors in human choriocarcinoma JEG-3 cells and normal human placenta. Endocrinology 1995; 136: 3163-72.
30. Lo HW, Hsu SC, Ali-Seyed M, Gunduz M., Xia W, Wei Y, et al Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 2005; 7: 575-89.
31. Lo HW, Xia W, Wei Y., Ali-Seyed M, Huang SF, Hung MC Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res 2005; 65: 338-48.
32. Yuen HF, Chua CW, Chan YP, Wong YC, Wang X, Chan KW. Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer. Histopathology 2007; 50: 648-58.
33. Yuen HF, Kwok WK, Chan K.K., Chua CW, Chan YP, Chu YY, et al TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction. Carcinogenesis 2008; 29: 1509-18.
34. Sokol NS, Ambros V. Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev 2005; 19: 2343-54.
35. Hobert O. Gene regulation by transcription factors and microRNAs. Science 2008; 319: 1785-6.
36. Re A, Cora D, Taverna D., Caselle M. Genome-wide survey of microRNA-transcription factor feed-forward regulatory circuits in human. Mol Biosyst 2009; 5: 854-67.
37. Lagos-Quintana M., Rauhut R, Yalcin A., Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002; 12:735-9.